🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to standardized the process of mini-invasive abdominal dran...
Status
Unknown
Location
Ruijin
Start Date
2013-08
Trial ID
NCT02002793
Treatments Being Tested
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
Ceftobiprole, a fifth-generation cephalosporin, exhibits potent antibacteri...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-12
Trial ID
NCT07127185
Treatments Being Tested
The aim of this study was to evaluate the effects of periodontal treatment ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT03005886
Treatments Being Tested
This trial studies nipple aspirate fluid in detecting breast cancer. Nipple...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2020-12-10
Trial ID
NCT03715959
Treatments Being Tested
Fluid responsiveness assessment is a major issue in intensive care. Since f...
Status
Completed
Location
Site Sud - CHU d'Amiens Picardie
Start Date
2024-03-19
Trial ID
NCT07073859
Treatments Being Tested
The aim of this project is to test the utility of The Gene Z device (as of ...
Status
Recruiting
Location
University of Michigan Health/Sparrow (name change only)
Start Date
2015-06
Trial ID
NCT01904188
This study aimed to investigate gingival crevicular fluid (GCF) and serum l...
Status
Completed
Location
Giresun University
Start Date
2019-09-30
Trial ID
NCT04383561
Treatments Being Tested
This is a prospective investigation which aims to address key challenges to...
Status
Completed
Location
University of Wisconsin
Start Date
2021-09-13
Trial ID
NCT04818060
Treatments Being Tested
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested